Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
22.08BDT
605.42 MBDT
9.13 BBDT
17.29 M
About THE IBN SINA PHARMACEUTICAL INDUSTRY PLC
Sector
CEO
A. K. M. Sadrul Islam
Headquarters
Dhaka
Website
Founded
1983
ISIN
BD0464IBNSN2
FIGI
BBG000BPF610
The IBN SINA Pharmaceutical Industry Plc engages in the manufacture and sale of pharmaceutical drugs and medicines. It includes traditional herbal and unani medicines. The company was founded on December 22, 1983 and is headquartered in Dhaka, Bangladesh.
Frequently Asked Questions
The current price of IBNSINA is 359.00 BDT — it has decreased by −1.75% in the past 24 hours. Watch THE IBN SINA PHARMACEUTICAL INDUSTRY PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on DSEBD exchange THE IBN SINA PHARMACEUTICAL INDUSTRY PLC stocks are traded under the ticker IBNSINA.
IBNSINA stock has risen by 3.40% compared to the previous week, the month change is a 16.14% rise, over the last year THE IBN SINA PHARMACEUTICAL INDUSTRY PLC has showed a 25.26% increase.
IBNSINA reached its all-time high on Sep 25, 2024 with the price of 384.80 BDT, and its all-time low was 47.70 BDT and was reached on May 9, 2013. View more price dynamics on IBNSINA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IBNSINA stock is 3.50% volatile and has beta coefficient of 1.64. Track THE IBN SINA PHARMACEUTICAL INDUSTRY PLC stock price on the chart and check out the list of the most volatile stocks — is THE IBN SINA PHARMACEUTICAL INDUSTRY PLC there?
Today THE IBN SINA PHARMACEUTICAL INDUSTRY PLC has the market capitalization of 11.34 B, it has increased by 4.62% over the last week.
Yes, you can track THE IBN SINA PHARMACEUTICAL INDUSTRY PLC financials in yearly and quarterly reports right on TradingView.
THE IBN SINA PHARMACEUTICAL INDUSTRY PLC is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
IBNSINA net income for the last quarter is 134.55 M BDT, while the quarter before that showed 209.28 M BDT of net income which accounts for −35.71% change. Track more THE IBN SINA PHARMACEUTICAL INDUSTRY PLC financial stats to get the full picture.
Yes, IBNSINA dividends are paid annually. The last dividend per share was 6.00 BDT. As of today, Dividend Yield (TTM)% is 1.65%. Tracking THE IBN SINA PHARMACEUTICAL INDUSTRY PLC dividends might help you take more informed decisions.
THE IBN SINA PHARMACEUTICAL INDUSTRY PLC dividend yield was 2.09% in 2023, and payout ratio reached 30.96%. The year before the numbers were 2.02% and 30.94% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 30, 2024, the company has 4.00 K employees. See our rating of the largest employees — is THE IBN SINA PHARMACEUTICAL INDUSTRY PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THE IBN SINA PHARMACEUTICAL INDUSTRY PLC EBITDA is 1.17 B BDT, and current EBITDA margin is 11.49%. See more stats in THE IBN SINA PHARMACEUTICAL INDUSTRY PLC financial statements.
Like other stocks, IBNSINA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THE IBN SINA PHARMACEUTICAL INDUSTRY PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THE IBN SINA PHARMACEUTICAL INDUSTRY PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THE IBN SINA PHARMACEUTICAL INDUSTRY PLC stock shows the strong buy signal. See more of THE IBN SINA PHARMACEUTICAL INDUSTRY PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.